Picardo Sherman, Altuwaijri Mansour, Devlin Shane M, Seow Cynthia H
Inflammatory Bowel Disease Unit, Department of Gastroenterology, Cumming School of Medicine, University of Calgary, AB, Canada.
Inflammatory Bowel Disease Unit, Department of Gastroenterology, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive, TRW Building, Room 6D18, Calgary, AB T2N 4Z6, Canada.
Therap Adv Gastroenterol. 2020 May 26;13:1756284820927550. doi: 10.1177/1756284820927550. eCollection 2020.
The use of complementary and alternative medications (CAM), products, and therapies not considered to be part of conventional medicine is common among patients with inflammatory bowel disease (IBD). Patients often turn to these therapies as they are considered natural and safe, with significant benefit reported beyond disease control. There is emerging evidence that some of these therapies may have anti-inflammatory activity; however, robust evidence for their efficacy in modulating disease activity is currently lacking. Patients often avoid discussing the use of CAM with their physicians, which may lead to drug interactions and/or reduced adherence with conventional therapy. It is important for physicians to be aware of the commonly used CAM and current evidence behind these therapies in order to better counsel their patients about their use in the management of IBD. This narrative review provides an overview of the evidence of the more commonly used CAM in patients with IBD.
在炎症性肠病(IBD)患者中,使用不被视为传统医学一部分的补充和替代药物(CAM)、产品及疗法很常见。患者常常求助于这些疗法,因为它们被认为天然且安全,而且据报道除了疾病控制之外还有显著益处。越来越多的证据表明,其中一些疗法可能具有抗炎活性;然而,目前缺乏关于它们调节疾病活动疗效的有力证据。患者常常避免与医生讨论使用CAM的情况,这可能导致药物相互作用和/或降低对传统疗法的依从性。医生了解常用的CAM及其背后的现有证据很重要,以便更好地就其在IBD管理中的使用向患者提供咨询。本叙述性综述概述了IBD患者中较常用CAM的证据。